Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2 -transformed human urothelial cells

Toxicological Sciences

Volumn 93, Issue 2, 2006, Pages 322-330

  Zhou, Xu Dong ^a   Sens, Mary Ann ^a   Garrett, Scott H ^a   Somji, Seema ^a   Park, Seongmi ^a   Gurel, Volkan ^a   Sens, Donald A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Arsenic; Bladder cancer; Cadmium; Metallothionein, biomarker; Transformation

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CADMIUM; ISOPROTEIN; MESSENGER RNA; METALLOTHIONEIN III;

ARTICLE; BENIGN TUMOR; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER GRADING; CARCINOMA IN SITU; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UROTHELIUM;

ANIMALS; ARSENIC; BREAST NEOPLASMS; CADMIUM; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOTHIONEIN; MICE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

MUS MUSCULUS;

EID: 33748746052     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl065     Document Type: Article

References (20)

1. Andrews, G. K. (2000). Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59, 95-104.
2. Borden, L. S., Jr., Clark, P. E., and Hall, M. C. (2004). Bladder Cancer. Curr. Opin. Oncol. 16(3), 257-262.
3. Detrisac, C. J., Mayfield, R. K., Colwell, J. A., Garvin, A. J., and Sens, D. A. (1983). In vitro culture of cells exfoliated in the urine by patients with diabetes mellitus. J. Clin. Invest. 71, 170-173.
4. Dutta, R., Sens, D. A., Somji, S., Sens, M. A., and Garrett, S. H. (2002). Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate 52, 89-97.
5. Epstein, J. I., Amin, M. B., Reuter, V. R., and Mostofi, F. K. (1998). The World Health Organization, International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 12, 1435-1438.
6. Friedline, J. A., Garrett, S. H., Somji, S., Todd, J. H., and Sens, D. A. (1998). Differential expression of the MT-1E gene in estrogen receptor positive and negative human breast cancer cell lines. Am. J. Pathol. 152, 23-28.
7. Garrett, S. H., Park, S., Sens, M. A., Somji, S., Singh, R. K., Namburi, V. B. R. K., and Sens, D. A. (2005). Expression of metallothionein isoform 3 is restricted at the post-transcriptional level in human bladder epithelial cells. Toxicol. Sci. 87, 66-74.
8. Garrett, S. H., Sens, M. A., Shukla, D., Nestor, S., Somji, S., Todd, J. H., and Sens, D. A. (1999a). Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. Prostate 41, 196-202.
9. Garrett, S. H., Sens, M. A., Todd, J. H., Somji, S., and Sens, D. A. (1999b). Expression of MT-3 protein in the human kidney. Toxicol. Lett. 105, 207-214.
10. Gurel, V., Sens, D. A., Somji, S., Garrett, S. H., Nath, J., and Sens, M. A. (2003). Stable transfection and overexpression of metallothionein isoform 3 inhibits the growth of MCF-7 and Hs578T cells but not that of T-47D or MDA-MB-231 cells. Breast Cancer Res. Treat. 80, 181-191.
11. Hamer, D. H. (1986). Metallothionein. Annu. Rev. Biochem. 55, 913-951.
12. Knowles, M. A. (2006). Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27, 361-373.
13. Petzoldt, J. L., Leigh, I. M., Duffy, P. G., and Masters, J. R. W. (1994). Culture and characterization of human urothelium in vivo and in vitro. Urol. Res. 22, 67-74.
14. Petzoldt, J. L., Leigh, I. M., Duffy, P. C., Sexton, C., and Masters, J. R. W. (1995). Immortalization of human urothelial cells. Urol. Res. 23, 377-380.
15. Rossi, M. R., Masters, J. R. W., Park, S., Todd, J. H., Garrett, S. H., Sens, M. A., Somji, S., Nath, J., and Sens, D. A. (2001). The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ. Health Perspect. 109, 801-808.
16. Sens, D. A., Park, S., Gurel, V., Sens, M. A., Garrett, S. H., and Somji, S. (2004). Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol. Sci. 79, 56-63.
17. Sens, M. A., Somji, S., Garrett, S. H., and Sens, D. A. (2001). Metallothionein isoform 3 (MT-3) overexpression is associated with breast cancers having a poor prognosis. Am. J. Pathol. 159, 21-26.
18. Sens, M. A., Somji, S., Lamm, D. L., Garrett, S. G., Slovinsky, F., Todd, J. H., and Sens, D. A. (2000). Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ. Health Perspect. 108, 413-418.
19. +2. Toxicol. Sci. 90, 369-376.
20. Zhou, X. D., Sens, D. A., Sens, M. A., Namburi, V. B., Singh, R. K., Garrett, S. H., and Somji, S. (2006). Metallothionein-1 and -2 expression in cadmium and arsenite derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer. Toxicol. Sci. 91(2), 467-475.